Company profile: Valeritas
1.1 - Company Overview
Company description
- Provider of innovative drug delivery solutions for Type 2 diabetes, including V-GO, a disposable insulin pump, and a micro needle patch, leveraging h-Patch technology to improve clinical and humanistic outcomes for patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Valeritas
PLx Pharma
HQ: United States
Website
- Description: Provider of non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets, developing and commercializing these therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLx Pharma company profile →
Nurse Assist
HQ: United States
Website
- Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nurse Assist company profile →
TriSalus
HQ: United States
Website
- Description: Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriSalus company profile →
Oval Medical Technologies
HQ: United States
Website
- Description: Provider of specialty pharmaceutical autoinjector platforms: ArQ subcutaneous two-step autoinjector with audible feedback, compatible with various viscosities, volumes, and needle gauges; Bios platform for large-volume, ultra-high viscosity formulations using ISO-standard plunger stoppers and staked-needle syringes; Vita resuspension platform for delivering large volumes with a dry-needle system for long-acting formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oval Medical Technologies company profile →
Bioject
HQ: United States
Website
- Description: Provider of needle-free injection therapies to improve administration of liquid medications, including pharmaceuticals, vaccines, and biologics, using technology that forces medication at high speed through a tiny orifice held against the skin, with over 25 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioject company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Valeritas
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Valeritas
2.2 - Growth funds investing in similar companies to Valeritas
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Valeritas
4.2 - Public trading comparable groups for Valeritas
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →